There are 2949 resources available
IO combinations in first-line advanced HCC: Current evidence and ongoing trials
Presenter: Peter Galle
Session: AstraZeneca - Current status and future directions for immunotherapy in hepatocellular carcinoma
Resources:
Webcast
IO combinations early or intermediate-stage HCC: Current evidence and ongoing trials
Presenter: Ghassan Abou-Alfa
Session: AstraZeneca - Current status and future directions for immunotherapy in hepatocellular carcinoma
Resources:
Webcast
Putting it all together: Case discussions
Presenter: Bruno Sangro
Session: AstraZeneca - Current status and future directions for immunotherapy in hepatocellular carcinoma
Resources:
Webcast
Summary, final thoughts, and audience question and answer session
Presenter: Ghassan Abou-Alfa
Session: AstraZeneca - Current status and future directions for immunotherapy in hepatocellular carcinoma
Resources:
Webcast
Welcome and introduction
Presenter: Neal Shore
Session: PeerVoice - Extending overall survival in nmCRPC while maintaining quality of life: Can we have it all?
Resources:
Webcast
Expanding the potential of PARP inhibitors
Presenter: Joaquin Mateo
Session: Pfizer Oncology - Building a new paradigm in prostate cancer
Resources:
Webcast
Summary
Presenter: Daniel George
Session: Pfizer Oncology - Building a new paradigm in prostate cancer
Resources:
Webcast
Optimising care for individual patients with metastatic hormone sensitive prostate cancer
Presenter: Nicolas Mottet
Session: Janssen - Advanced prostate cancer: How do we move forward in patient management?
Resources:
Webcast
Non metastatic castration resistant prostate cancer translating benefit to clinical practice & Choosing the right pathway in the current and future management of metastatic castration resistant prostate cancer
Presenter: Nicolas Mottet
Session: Janssen - Advanced prostate cancer: How do we move forward in patient management?
Resources:
Webcast
Overall survival in nmCRPC: Translating recent data into a plan of action
Presenter: Jennifer Sutton
Session: PeerVoice - Extending overall survival in nmCRPC while maintaining quality of life: Can we have it all?
Resources:
Webcast